Percutanous closure of patent ductus arteriosus in small infants of less than 8�kg body weight using different devices

Closure of Small Patent Ductus Arteriosus by Occluding Detachable Coil

Intravenous Paracetamol and Patent Ductus Arteriosus Closure

Background: Standard medical treatments for patent ductus arteriosus (PDA) closure are, including indomethacin/ibuprofen and surgical ligation. Nowadays, a new strategy to close PDA is the use of paracetamol. The present study aimed to describe the use of intravenous (IV) paracetamol for PDA closure in neonates who present a contraindication to ibuprofen or ibuprofen failure with no possibility...

closure of small patent ductus arteriosus by occluding detachable coil

0

Percutaneous closure of patent ductus arteriosus in preterm infants.

Patent ductus arteriosus (PDA) is found in more than 60% of preterm infants born at a gestational age of less than 28 weeks.1,2 The therapeutic approach to PDA consists of medical treatment with indomethacin or ibuprofen, and surgical ligation or stapling as salvage therapy. Surgery is not free of complications,2-4 with a mortality risk that ranges between 1% and 10%.2,5,6 We present the case o...

Percutaneous closure of patent ductus arteriosus in adults using different devices.

Surgical closure of patent ductus arteriosus in adults involves a number of risks because there are associated anatomic and histologic alterations. Between October 1992 and August 2008, 23 patients were referred to our department with isolated patent ductus arteriosus. Their age ranged from 16-75 years (median 25.5 years) and their weight from 52-80 kg (median 57 kg). The pulmonary diameter ran...